MedPath

Efficacy and pregnancy outcome of oral metronidazole versus oral clindamycin for treating bacterial vaginosis in pregnancy at Ilorin, Nigeria. A randomized control trial.

Not Applicable
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202304665943139
Lead Sponsor
self funded
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
500
Inclusion Criteria

•All consenting pregnant women attending antenatal clinic at the study site between 20 and 26weeks of gestation.
•Single live intrauterine foetus
•Desire to deliver at the study site.

Exclusion Criteria

•Use of antibiotics in the preceding two weeks before recruitment into the study.
•Allergy to metronidazole or clindamycin
•Previous history of preterm birth
•Previous and present history of preterm premature rupture of membrane (SPROM)
•Patient on cerclage.
•Chronic medical disorders that can predispose to preterm birth such as diabetes mellitus, lentiviral infection and hypertensive disorders in pregnancy.
•Multiple pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath